Explore the fascinating story of WARF's licensing policies for embryonic stem cell lines and how intellectual property battles shaped modern regenerative medicine.
Exploring how patents and licensing issues are delaying stem cell therapy breakthroughs and the scientific efforts to overcome these hurdles.